Axonics Modulation Technologies Inc logo

AXNX

Axonics Modulation Technologies Inc

$67.47

Earnings Summary

Revenue
$0.2Mn
Net Profits
$-7.57Mn
Net Profit Margins
-3764.18%

Highlights

Revenue:

Axonics Modulation Technologies Inc’s revenue jumped 57.03% since last year same period to $0.2Mn in the Q3 2018. On a quarterly growth basis, Axonics Modulation Technologies Inc has generated 1575% jump in its revenue since last 3-months.

Net Profits:

Axonics Modulation Technologies Inc’s net profit fell -67.32% since last year same period to $-7.57Mn in the Q3 2018. On a quarterly growth basis, Axonics Modulation Technologies Inc has generated 12.51% jump in its net profits since last 3-months.

Net Profit Margins:

Axonics Modulation Technologies Inc’s net profit margin fell -6.55% since last year same period to -3764.18% in the Q3 2018. On a quarterly growth basis, Axonics Modulation Technologies Inc has generated 94.78% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Axonics Modulation Technologies Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.41
EPS Estimate Current Year
-0.41

Highlights

EPS Estimate Current Quarter:

Axonics Modulation Technologies Inc’s earning per share (EPS) estimates for the current quarter stand at -0.41 - a 13.71% jump from last quarter’s estimates.

EPS Estimate Current Year:

Axonics Modulation Technologies Inc’s earning per share (EPS) estimates for the current year stand at -0.41.

Key Ratios

Key ratios of the Axonics Modulation Technologies Inc post its Q2 2022 earnings

Earning Per Share (EPS)
-0.47
Return on Assets (ROA)
-0.06
Return on Equity (ROE)
-0.15

Highlights

Earning Per Share (EPS):

Axonics Modulation Technologies Inc’s earning per share (EPS) jumped 20.34% since last year same period to -0.47 in the Q2 2022. This indicates that the Axonics Modulation Technologies Inc has generated 20.34% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Axonics Modulation Technologies Inc’s return on assets (ROA) stands at -0.06.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Axonics Modulation Technologies Inc’s return on equity (ROE) stands at -0.15.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-01
-0.55
-0.47
14.31%
2022-05-05
-0.63
-0.5
21.02%

Company Information

Based in Irvine, Calif., Axonics has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for patients with bladder and bowel dysfunction, and through its acquisition of Bulkamid®, offers a best-in-class urethral bulking agent for women with stress urinary incontinence. These conditions significantly impact quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. Stress urinary incontinence affects an estimated 20 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries.

Organisation
Axonics Modulation Technologies Inc
Headquarters
26 Technology Drive, Irvine, CA, United States, 92618
Employees
517
Industry
Health Technology
CEO
Raymond Cohen

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*